Not Yet Recruiting
NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers
NCT07060014
- Conditions
- Advanced Small Intestine Cancer, Appendiceal Cancers
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States